Abstract
Despite recent progress in surgical procedures and therapeutic modalities, the outcomes of treatment for pancreas cancer are still not satisfactory. Chemotherapy can provide symptom relief in some patients, but its impact on survival has been modest and it can lead to unacceptable levels of toxicity. To develop novel and potentially less toxic forms of cancer therapy, molecular targeting therapy is being based initially on the knowledge of cellular signal transduction. The new approaches in treatment have originated from biochemical studies in combination with recent technology to block the progress of carcinogenesis or invasion. As one of the most successful of such agents, an antibody or antagonist against the receptor of epidermal growth factor or vascular endothelial growth factor has been proven in carcinoma treatment, and recent steps have been taken to apply this type of treatment to pancreas cancer. However, there are still serious problems for these receptor-associated signaling blockers; namely, the antibody or antagonist has no efficacy if the target cells grow independently of the receptor-related signaling. On the other hands, extra-cellular signal-regulated kinase (ERK) is well known to represent a convergent point for the intracellular signaling pathways in whole cancer cells. In the present, by reviewing our recent studies that evaluate the usefulness of the vitamin K3 (menadione, 2-methyl-1,4-naphthoquinone; VK3)-induced growth inhibitory effect through ERK pathway, this novel approach to cancer therapy and its potential in future clinical applications will be highlighted.
Keywords: Vitamin K3 (menadione), extracellular signal-regulated protein kinase (ERK), molecular targeting therapy, pancreas cancer, drug delivery system, endoscopic ultrasound (EUS)-guided fine-needle injection (FNI)
Anti-Cancer Agents in Medicinal Chemistry
Title: A Novel Strategy for Advanced Pancreatic Cancer-Progression of Molecular Targeting Therapy
Volume: 9 Issue: 8
Author(s): Shinji Osada and Kazuhiro Yoshida
Affiliation:
Keywords: Vitamin K3 (menadione), extracellular signal-regulated protein kinase (ERK), molecular targeting therapy, pancreas cancer, drug delivery system, endoscopic ultrasound (EUS)-guided fine-needle injection (FNI)
Abstract: Despite recent progress in surgical procedures and therapeutic modalities, the outcomes of treatment for pancreas cancer are still not satisfactory. Chemotherapy can provide symptom relief in some patients, but its impact on survival has been modest and it can lead to unacceptable levels of toxicity. To develop novel and potentially less toxic forms of cancer therapy, molecular targeting therapy is being based initially on the knowledge of cellular signal transduction. The new approaches in treatment have originated from biochemical studies in combination with recent technology to block the progress of carcinogenesis or invasion. As one of the most successful of such agents, an antibody or antagonist against the receptor of epidermal growth factor or vascular endothelial growth factor has been proven in carcinoma treatment, and recent steps have been taken to apply this type of treatment to pancreas cancer. However, there are still serious problems for these receptor-associated signaling blockers; namely, the antibody or antagonist has no efficacy if the target cells grow independently of the receptor-related signaling. On the other hands, extra-cellular signal-regulated kinase (ERK) is well known to represent a convergent point for the intracellular signaling pathways in whole cancer cells. In the present, by reviewing our recent studies that evaluate the usefulness of the vitamin K3 (menadione, 2-methyl-1,4-naphthoquinone; VK3)-induced growth inhibitory effect through ERK pathway, this novel approach to cancer therapy and its potential in future clinical applications will be highlighted.
Export Options
About this article
Cite this article as:
Osada Shinji and Yoshida Kazuhiro, A Novel Strategy for Advanced Pancreatic Cancer-Progression of Molecular Targeting Therapy, Anti-Cancer Agents in Medicinal Chemistry 2009; 9 (8) . https://dx.doi.org/10.2174/187152009789124691
DOI https://dx.doi.org/10.2174/187152009789124691 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
Call for Papers in Thematic Issues
Induction of cell death in cancer cells by modulating telomerase activity using small molecule drugs
Telomeres are distinctive but short stretches present at the corners of chromosomes and aid in stabilizing chromosomal makeup. Resynthesis of telomeres supported by the activity of reverse transcriptase ribonucleoprotein complex telomerase. There is no any telomerase activity in human somatic cells, but the stem cells and germ cells undergone telomerase ...read more
Role of natural compounds as anti anti-cancer agents
Cancer is considered the leading cause of worldwide mortality, accounting for nearly 10 million deaths in 2022. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy remains an important approach in treatment o f several types of cancers, even though ...read more
Signaling and enzymatic modulators in cancer treatment
Cancer accounts for nearly 10 million deaths in 2022 and is considered the leading cause of worldwide mortality. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy, radiotherapy and surgery are the most important approach for the treatment of several ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy
Current Pharmaceutical Design Evaluation of the Influence of the Conjugation Site of the Chelator Agent HYNIC to GLP1 Antagonist Radiotracer for Insulinoma Diagnosis
Current Radiopharmaceuticals Poly(ADP-Ribosylation): Beneficial Effects of Its Inhibition
Current Enzyme Inhibition Anticancer Actions of Omega-3 Fatty Acids - Current State and Future Perspectives
Anti-Cancer Agents in Medicinal Chemistry Plant Glycosides and Aglycones Displaying Antiproliferative and Antitumour Activities – A Review
Current Bioactive Compounds Immune Receptors, Cadherins and their Interactions
Current Immunology Reviews (Discontinued) Investigating Drug Repositioning Approach to Design Novel Prodrugs for Colon-specific Release of Fexofenadine for Ulcerative Colitis
Current Drug Delivery Vitamin, Mineral, and Drug Absorption Following Bariatric Surgery
Current Drug Metabolism Targeting the Mevalonate Pathway for Improved Anticancer Therapy
Current Cancer Drug Targets AMPK as a New Attractive Therapeutic Target for Disease Prevention: The Role of Dietary Compounds AMPK and Disease Prevention
Current Drug Targets Prevalence of Vertebral Fractures, Vascular Calcifications, and Mortality in Warfarin Treated Hemodialysis Patients
Current Vascular Pharmacology How to Make a Non-Antigenic Protein (Auto) Antigenic: Molecular Complementarity Alters Antigen Processing and Activates Adaptive-Innate Immunity Synergy
Anti-Cancer Agents in Medicinal Chemistry A Hybrid Discrete Imperialist Competition Algorithm for Gene Selection for Microarray Data
Current Proteomics No miR Quirk: Dysregulation of microRNAs in Pancreatic Ductal Adenocarcinoma
MicroRNA Anticoagulant Therapy in Pregnant Patients with Metabolic Syndrome: A Review
Current Pharmaceutical Biotechnology Telocytes as a Source of Progenitor Cells in Regeneration and Repair Through Granulation Tissue
Current Stem Cell Research & Therapy Natural Molecules as Talented Inhibitors of Nucleotide Pyrophosphatases/ Phosphodiesterases (PDEs)
Current Topics in Medicinal Chemistry Glioblastoma Stem-Like Cells – Isolation, Biology and Mechanisms of Chemotherapy Resistance
Current Signal Transduction Therapy Potential of Selected Antioxidants for Influenza Chemotherapy
Anti-Infective Agents in Medicinal Chemistry Metabolomics of Serum Peptides
Protein & Peptide Letters